首页> 外文期刊>Cancers >Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
【24h】

Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?

机译:靶向癌症中的热休克蛋白27:癌症治疗的可毒靶点?

获取原文
获取外文期刊封面目录资料

摘要

Heat shock protein 27 (HSP27), induced by heat shock, environmental, and pathophysiological stressors, is a multi-functional protein that acts as a protein chaperone and an antioxidant. HSP27 plays a significant role in the inhibition of apoptosis and actin cytoskeletal remodeling. HSP27 is upregulated in many cancers and is associated with a poor prognosis, as well as treatment resistance, whereby cells are protected from therapeutic agents that normally induce apoptosis. This review highlights the most recent findings and role of HSP27 in cancer, as well as the strategies for using HSP27 inhibitors for therapeutic purposes.
机译:通过热冲击,环境和病理生理酶应激源引起的热休克蛋白27(HSP27)是一种多功能蛋白,其充当蛋白质伴侣和抗氧化剂。 HSP27在抑制细胞凋亡和肌动蛋白细胞骨架重塑中起着重要作用。 HSP27在许多癌症中上调,并且预后差和治疗抗性有关,其中细胞免受通常诱导细胞凋亡的治疗剂。本综述突出了HSP27在癌症中最新的发现和作用,以及使用HSP27抑制剂进行治疗目的的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号